BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 31950392)

  • 1. Breast brain metastases are associated with increased risk of leptomeningeal disease after stereotactic radiosurgery: a systematic review and meta-analysis.
    Brown DA; Lu VM; Himes BT; Burns TC; Quiñones-Hinojosa A; Chaichana KL; Parney IF
    Clin Exp Metastasis; 2020 Apr; 37(2):341-352. PubMed ID: 31950392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for leptomeningeal carcinomatosis in patients with brain metastases who have previously undergone stereotactic radiosurgery.
    Huang AJ; Huang KE; Page BR; Ayala-Peacock DN; Lucas JT; Lesser GJ; Laxton AW; Tatter SB; Chan MD
    J Neurooncol; 2014 Oct; 120(1):163-9. PubMed ID: 25048529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptomeningeal disease following stereotactic radiosurgery for brain metastases from breast cancer.
    Trifiletti DM; Romano KD; Xu Z; Reardon KA; Sheehan J
    J Neurooncol; 2015 Sep; 124(3):421-7. PubMed ID: 26093620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases.
    Atalar B; Modlin LA; Choi CY; Adler JR; Gibbs IC; Chang SD; Harsh GR; Li G; Nagpal S; Hanlon A; Soltys SG
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):713-8. PubMed ID: 24054875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical Resection of Brain Metastases and the Risk of Leptomeningeal Recurrence in Patients Treated With Stereotactic Radiosurgery.
    Johnson MD; Avkshtol V; Baschnagel AM; Meyer K; Ye H; Grills IS; Chen PY; Maitz A; Olson RE; Pieper DR; Krauss DJ
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):537-43. PubMed ID: 26867883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
    Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
    J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa.
    Suki D; Abouassi H; Patel AJ; Sawaya R; Weinberg JS; Groves MD
    J Neurosurg; 2008 Feb; 108(2):248-57. PubMed ID: 18240919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of leptomeningeal disease following hypofractionated stereotactic radiotherapy for intact and resected brain metastases.
    Nguyen TK; Sahgal A; Detsky J; Atenafu EG; Myrehaug S; Tseng CL; Husain Z; Heyn C; Maralani P; Ruschin M; Perry J; Soliman H
    Neuro Oncol; 2020 Jan; 22(1):84-93. PubMed ID: 31412120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward the complete control of brain metastases using surveillance screening and stereotactic radiosurgery.
    Wolf A; Kvint S; Chachoua A; Pavlick A; Wilson M; Donahue B; Golfinos JG; Silverman J; Kondziolka D
    J Neurosurg; 2018 Jan; 128(1):23-31. PubMed ID: 28298015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of leptomeningeal carcinomatosis in patients with brain metastases treated with stereotactic radiosurgery.
    Ma R; Levy M; Gui B; Lu SE; Narra V; Goyal S; Danish S; Hanft S; Khan AJ; Malhotra J; Motwani S; Jabbour SK
    J Neurooncol; 2018 Jan; 136(2):395-401. PubMed ID: 29159778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic radiosurgery for focal leptomeningeal disease in patients with brain metastases.
    Wolf A; Donahue B; Silverman JS; Chachoua A; Lee JK; Kondziolka D
    J Neurooncol; 2017 Aug; 134(1):139-143. PubMed ID: 28536993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posterior fossa metastases: risk of leptomeningeal disease when treated with stereotactic radiosurgery compared to surgery.
    Siomin VE; Vogelbaum MA; Kanner AA; Lee SY; Suh JH; Barnett GH
    J Neurooncol; 2004; 67(1-2):115-21. PubMed ID: 15072456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience.
    Kingston B; Kayhanian H; Brooks C; Cox N; Chaabouni N; Redana S; Kalaitzaki E; Smith I; O'Brien M; Johnston S; Parton M; Noble J; Stanway S; Ring A; Turner N; Okines A
    Breast; 2017 Dec; 36():54-59. PubMed ID: 28968585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative risk of leptomeningeal dissemination of cancer after surgery or stereotactic radiosurgery for a single supratentorial solid tumor metastasis.
    Suki D; Hatiboglu MA; Patel AJ; Weinberg JS; Groves MD; Mahajan A; Sawaya R
    Neurosurgery; 2009 Apr; 64(4):664-74; discussion 674-6. PubMed ID: 19197219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemorrhagic and Cystic Brain Metastases Are Associated With an Increased Risk of Leptomeningeal Dissemination After Surgical Resection and Adjuvant Stereotactic Radiosurgery.
    Press RH; Zhang C; Chowdhary M; Prabhu RS; Ferris MJ; Xu KM; Olson JJ; Eaton BR; Shu HG; Curran WJ; Crocker IR; Patel KR
    Neurosurgery; 2019 Nov; 85(5):632-641. PubMed ID: 30335175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic Landscape.
    Nguyen A; Nguyen A; Dada OT; Desai PD; Ricci JC; Godbole NB; Pierre K; Lucke-Wold B
    Curr Oncol; 2023 Jun; 30(6):5906-5931. PubMed ID: 37366925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nodular Leptomeningeal Disease-A Distinct Pattern of Recurrence After Postresection Stereotactic Radiosurgery for Brain Metastases: A Multi-institutional Study of Interobserver Reliability.
    Turner BE; Prabhu RS; Burri SH; Brown PD; Pollom EL; Milano MT; Weiss SE; Iv M; Fischbein N; Soliman H; Lo SS; Chao ST; Cox BW; Murphy JD; Li G; Gephart MH; Nagpal S; Atalar B; Azoulay M; Thomas R; Tillman G; Durkee BY; Shah JL; Soltys SG
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):579-586. PubMed ID: 31605786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DEGRO guideline for personalized radiotherapy of brain metastases and leptomeningeal carcinomatosis in patients with breast cancer.
    Borm KJ; Behzadi ST; Hörner-Rieber J; Krug D; Baumann R; Corradini S; Duma MN; Dunst J; Fastner G; Feyer P; Fietkau R; Haase W; Harms W; Hehr T; Matuschek C; Piroth MD; Schmeel LC; Souchon R; Strnad V; Budach W; Combs SE;
    Strahlenther Onkol; 2024 Apr; 200(4):259-275. PubMed ID: 38488902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
    Griguolo G; Pouderoux S; Dieci MV; Jacot W; Bourgier C; Miglietta F; Firmin N; Conte P; Viala M; Guarneri V; Darlix A
    Oncologist; 2018 Nov; 23(11):1289-1299. PubMed ID: 30120164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC).
    Shuto T; Akabane A; Yamamoto M; Serizawa T; Higuchi Y; Sato Y; Kawagishi J; Yamanaka K; Jokura H; Yomo S; Nagano O; Aoyama H
    J Neurosurg; 2018 Dec; 129(Suppl1):86-94. PubMed ID: 30544291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.